Intervention Review

Drug treatment for spinal muscular atrophy types II and III

  1. Renske I Wadman1,*,
  2. Wendy MJ Bosboom2,
  3. W Ludo van der Pol1,
  4. Leonard H van den Berg1,
  5. John HJ Wokke1,
  6. Susan T Iannaccone3,
  7. Alexander FJE Vrancken1

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 18 APR 2012

Assessed as up-to-date: 8 MAR 2011

DOI: 10.1002/14651858.CD006282.pub4

How to Cite

Wadman RI, Bosboom WMJ, van der Pol WL, van den Berg LH, Wokke JHJ, Iannaccone ST, Vrancken AFJE. Drug treatment for spinal muscular atrophy types II and III. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD006282. DOI: 10.1002/14651858.CD006282.pub4.

Author Information

  1. 1

    University Medical Center Utrecht, Department of Neurology, Utrecht, Netherlands

  2. 2

    Sint Lucas Andreas Hospital, Department of Neurology, Amsterdam, Netherlands

  3. 3

    University of Texas Southwestern Medical Center, Department of Pediatrics, Dallas, Texas, USA

*Renske I Wadman, Department of Neurology, University Medical Center Utrecht, Rudolf Magnus Institute for Neuroscience, Universiteitsweg 100, Utrecht, 3584 CG, Netherlands.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 APR 2012